中手遊(00302.HK)完成配發2.58億股籌資8.49億港元
格隆匯5月10日丨中手遊(00302.HK)宣佈,認購事項已於2021年5月10日完成。完成後,公司已向認購人配發及發行合共2.58億股認購股份。公司在完成後收到的所得款項淨額合共約為8.49億港元。公司擬透過收購及╱或投資(i)擁有良好研發能力的領先遊戲開發商,及(ii)在大中華與受歡迎的及具有潛力的動畫、文學作品、遊戲及電影有關的強大IP,將認購事項所得款項淨額用於進一步提升其IP遊戲發行及開發業務。
根據嗶哩嗶哩認購協議的條款,張聖晏先生獲委任為非執行董事,初步任期為由2021年5月10日生效起計三年或由2021年5月10日起直至公司第三次股東周年大會為止(按較早者為準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.